Neogenomics Inc (NEO)

Listed in the US · Services · Testing laboratories

$17.93

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $17.93 on 29 Oct 2026. The share price traded between $7.07 and $20.15 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $17.93

Low $7.07High $20.15

Market cap$2.3Blast close × shares
Net profit−$32.27Mlast 12 months
Return on equity−12.9%year to Dec 2025
EBITDA margin−11.0%year to Dec 2025
Debt to equity0.41year to Dec 2025
Net margin−14.9%year to Dec 2025
Dividend yieldnonelast 12 months

P/E isn't shown: the company made a loss over the last 12 months, and a loss has no P/E.

Price trend

Revenue and profit

RevenueNet profit$ million
-2500250500750
YearDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue484510592661727
Net profit-8-144-88-79-108
EBITDA margin-18.3%-24.0%-11.9%-8.0%-11.0%
Borrowings534535538541342

$ million. Over three years, compounded: revenue grew 12.6% a year.

Recent filings

Questions about Neogenomics Inc

What is Neogenomics Inc's market value?

Neogenomics Inc's market value is $2.3B as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with NEO

Free to start: test a trading idea on NEO's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Testing laboratories), by market value.

Same sector

The largest companies in the wider sector (Services), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.